Cyanosis screening

Revision as of 17:22, 6 November 2020 by Sara Zand (talk | contribs)
Jump to navigation Jump to search

Cyanosis Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cyanosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cyanosis screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cyanosis screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cyanosis screening

CDC on Cyanosis screening

Cyanosis screening in the news

Blogs on Cyanosis screening

Directions to Hospitals Treating Cyanosis

Risk calculators and risk factors for Cyanosis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]

Overview

Prenatal echocardiography and genetic testing are useful methods for early detection of cyanotic congenital heart disease.Postnatal pulse oximetry is recommended for diagnosis of cyanotic congenital heart disease

Screening

References

  1. Liu, Xiwang; Xu, Weize; Yu, Jiangen; Shu, Qiang (2019). "Screening for congenital heart defects: diversified strategies in current China". World Journal of Pediatric Surgery. 2 (1): e000051. doi:10.1136/wjps-2019-000051. ISSN 2516-5410.

Template:WH Template:WS